Nicholas J Reynolds Consultant Dermatologist Newcastle

Nicholas J Reynolds Consultant Dermatologist Newcastle

Nicholas J Reynolds Consultant Dermatologist Newcastle brings together deep clinical expertise and groundbreaking research. He works at Newcastle’s Royal Victoria Infirmary where he specialises in chronic inflammatory skin disease, including psoriasis and atopic eczema. Because of his dual clinical and academic career, patients and colleagues value both his knowledge and his dedication.

Academic Leadership and Contributions

Professor Nicholas J Reynolds also serves as Professor of Dermatology at Newcastle University. Furthermore, he acts as Deputy Lead for the Skin and Oral Disease Research theme within the NIHR Newcastle Biomedical Research Centre. His leadership role supports collaboration between clinicians, researchers, and students. As a result, his work strengthens both the university and the broader dermatology field.

Training and Professional Background

After qualifying in medicine from the University of London, Professor Reynolds gained dermatology and academic training in Bristol, Ann Arbor Michigan, USA, and Newcastle. This international pathway gave him strong foundations in both clinical practice and research. Because of this broad experience, he now offers a unique perspective that bridges global insights with local patient care.

Research Focus on Psoriasis and Atopic Eczema

Nicholas J Reynolds Consultant Dermatologist Newcastle continues to focus his research on psoriasis and atopic eczema. Additionally, his studies cover human models of skin disease, systems biology, and precision medicine. These efforts help create a deeper understanding of chronic skin disorders. More importantly, his research provides new directions for future therapies.

Leadership in Research Networks

In 2016, he became Director of Newcastle’s MRC/EPSRC Molecular Pathology Node. This was one of six UK units designed to bring together researchers, clinicians, and industry. Through this role, he advanced molecular diagnostic tools for personalised medicine until 2019. Moreover, he served as the inaugural Chair of UK TREND (Translational Research Network in Dermatology). He also held the position of President of the European Society for Dermatological Research (ESDR). These leadership roles highlight his ongoing commitment to advancing dermatology worldwide.

Collaborative Partnerships and Impact

Professor Reynolds is also a member of the Executive Team for The Psoriasis Stratification to Optimise Relevant Therapy (PSORT) consortium. This unique partnership includes five UK universities, ten pharmaceutical and diagnostic companies, the Psoriasis Association, and NHS partners. Together, this collaboration works to improve personalised therapy for patients with psoriasis. Because of this joint effort, innovation reaches patients more effectively and efficiently.